Although, the involvement of osteosarcoma CSCs in the drug resistance phenotype mediated by these lncRNAs has not been addressed, the silencing of lncRNA MSC-AS1 resulted in the inactivation of pathways with reported roles in stemness such as PI3K/AKT signaling [110]. This evidence concerns the gene AKT1 and osteosarcoma.